Shu Uin Gan

Dr. Shu Uin Gan

National University of Singapore, Singapore
orcid

Research Focus & Metrics

Academic Career Length

31Years (1996-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2013 in Cell Transplantation
Verified
Journal Article
Open access
MGMahmoud M. Gabr
Mahmoud M. Gabr
MZMahmoud M. Zakaria
Mahmoud M. Zakaria
ARAyman F. Refaie
Ayman F. Refaie
AIAmani M. Ismail
Amani M. Ismail
MAMona A. Abou-El-Mahasen
Mona A. Abou-El-Mahasen
MGMohamed A. Ghoneim
Mohamed A. Ghoneim
Harvesting, expansion, and directed differentiation of human bone marrow-derived mesenchymal stem cells (BM-MSCs) could provide an autologous source of surrogate β-cells that would alleviate the limitations of availability and/or allogenic rejection following pancreatic or islet transplantation. Bone marrow cells were obtained from three adult type 2 diabetic volunteers and three nondiabetic donors. After 3 days in culture, adherent MSCs were expanded for two passages. At passage 3, differentiation was carried out in a three-staged procedure. Cells were cultured in a glucose-rich medium containing several activation and growth factors. Cells were evaluated in vitro by flow cytometry, immunolabeling, RT-PCR, and human insulin and c-peptide release in responses to increasing glucose concentrations. One thousand cell clusters were inserted under the renal capsule of diabetic nude mice followed by monitoring of their diabetic status. At the end of differentiation, ~5–10% of cells were immunofluorescent for insulin, c-peptide or glucagon; insulin, and c-peptide were coexpressed. Nanogold immunolabeling for electron microscopy demonstrated the presence of c-peptide in the rough endoplasmic reticulum. Insulin-producing cells (IPCs) expressed transcription factors and genes of pancreatic hormones similar to those expressed by pancreatic islets. There was a stepwise increase in human insulin and c-peptide release by IPCs in response to increasing glucose concentrations. Transplantation of IPCs into nude diabetic mice resulted in control of their diabetic status for 3 months. The sera of IPC-transplanted mice contained human insulin and c-peptide but negligible levels of mouse insulin. When the IPC-bearing kidneys were removed, rapid return of diabetic state was noted. BM-MSCs from diabetic and nondiabetic human subjects could be differentiated without genetic manipulation to form IPCs that, when transplanted, could maintain euglycemia in diabetic mice for 3 months. Optimization of the culture conditions are required to improve the yield of IPCs and their functional performance.

1 September 2012 in Stem Cell Research
Verified
Journal Article
Closed access
HWHeming Wei
Heming Wei
GTGrace Tan
Grace Tan
MAManasi
Manasi
SQSuhua Qiu
Suhua Qiu
GKGeraldine Kong
Geraldine Kong
WSWinston Shim
Winston Shim

10 January 2012 in Journal of Cellular Biochemistry
Verified
Journal Article
Closed access
PDF file
ASArjunan Subramanian
Arjunan Subramanian
SGShu Uin Gan
Shu Uin Gan
NKNgo Kae‐Siang
Ngo Kae‐Siang
KGKalamegam Gauthaman
Kalamegam Gauthaman
ABArijit Biswas
Arijit Biswas
FCFong Chui‐Yee
Fong Chui‐Yee

29 August 2013 in Journal of Cellular Biochemistry
Verified
Journal Article
Closed access
PDF file
CFChui‐Yee Fong
Chui‐Yee Fong
KTKimberley Tam
Kimberley Tam
SCSuganya Cheyyatraivendran
Suganya Cheyyatraivendran
SGShu Uin Gan
Shu Uin Gan
KGKalamegam Gauthaman
Kalamegam Gauthaman
ABAriff Bongso
Ariff Bongso

1 July 1999 in The Journal of Immunology
Verified
Journal Article
Open access
PDF file
JGJoanna Galea-Lauri
Joanna Galea-Lauri
DDDavid Darling
David Darling
SGShu Uin Gan
Shu Uin Gan
LKLeonid Krivochtchapov
Leonid Krivochtchapov
MKMarcel Kuiper
Marcel Kuiper
FFFarzin Farzaneh
Farzin Farzaneh
The ability of NK cells to kill tumor cells is controlled by a balance between activating and inhibitory signals transduced by distinct receptors. In murine tumor models, the costimulatory molecule B7.1 not only acts as a positive trigger for NK-mediated cytotoxicity but can also overcome negative signaling transduced by MHC class I molecules. In this study, we have evaluated the potential of human B7.1-CD28 interaction as an activating trigger for human blood NK cells. Using multiparameter flow cytometric analysis and a panel of different CD28 mAbs, we show that human peripheral blood NK cells (defined by CD56+, CD16+, and CD3− surface expression) express the CD28 costimulatory receptor, with its detection totally dependent on the mAb used. In addition, the level of CD28 varies among individuals and on different NK cell lines, irrespective of CD28 steady-state mRNA levels. By performing Ab binding studies on T cells, our data strongly suggest that binding of two of the anti-CD28 Abs (clones 9.3 and CD28.2) is to a different epitope to that recognized by clones L293 and YTH913.12, which is perhaps modified in the CD28 molecule expressed by the NK cells. We also show that B7.1 enhances the NK-mediated lysis of NK-sensitive but not of NK-resistant tumor cells and that this increased lysis is dependent on CD28-B7 interactions as shown by the ability of Abs to block this lysis. Coculture of the B7.1-positive NK-sensitive cells also led to the activation of the NK cells, as determined by the expression of CD69, CD25, and HLA class II.

15 January 2013 in Cancer Research
Verified
Journal Article
Open access
PDF file
WHWeng Tong Ho
Weng Tong Ho
WPWan Lu Pang
Wan Lu Pang
SCSiew Meng Chong
Siew Meng Chong
ACAntonio Castella
Antonio Castella
SASuhail Al-Salam
Suhail Al-Salam
HSHerbert Schwarz
Herbert Schwarz
Hodgkin lymphoma is caused by a minority population of malignant Hodgkin and Reed–Sternberg (HRS) cells that recruit an abundance of inflammatory cells. The long-term survival of HRS cells among the vast majority of immune cells indicates that they have developed potent immune escape mechanisms. We report that the TNF receptor family member CD137 (TNFRSF9) is expressed on HRS cells, while normal B cells, from which HRS cells are most often derived, do not express CD137. In 48 of 53 cases of classical Hodgkin lymphoma, CD137 was detected on HRS cells. Ectopically expressed CD137 transferred by trogocytosis from HRS cells to neighboring HRS and antigen-presenting cells, which constitutively express the CD137 ligand (CD137L and TNFSF9), became associated with CD137L and the CD137–CD137L complex was internalized. Disappearance of CD137L from the surface of HRS and antigen-presenting cells led to reduced costimulation of T cells through CD137, reducing IFN-γ release and proliferation. Our results reveal a new regulatory mechanism for CD137L expression that mediates immune escape by HRS cells, and they identify CD137 as a candidate target for immunotherapy of Hodgkin lymphoma. Cancer Res; 73(2); 652–61. ©2012 AACR.